Last reviewed · How we verify
NCT05332886: MetaYouth
Metaverse-Based Healthy Life Program for Youth
NA trial testing MetaHealth Group in Health Risk Behaviors in 600 participants. Status unknown.
1 March 2025
Quick facts
| Lead sponsor | Ayşegül İşler Dalgıç |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 600 |
| Start date | 1 July 2024 |
| Primary completion | 1 March 2025 |
| Estimated completion | 1 May 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- MetaHealth Group
- MobileHealth Group
Conditions studied
- Health Risk Behaviors — all drugs for Health Risk Behaviors →
- Healthy Lifestyle — all drugs for Healthy Lifestyle →
- Non Communicable Diseases — all drugs for Non Communicable Diseases →
- Health-Related Behavior — all drugs for Health-Related Behavior →
Sponsor
Ayşegül İşler Dalgıç
Who can join
Adults 15 to 24, any sex, with Health Risk Behaviors or Healthy Lifestyle. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was planned within the scope of the call titled "Non-communicable diseases risk reduction in adolescence and youth (Global Alliance for Chronic Diseases - GACD)" with identity number HORIZON-HLTH-2022-DISEASE-07-03. The purpose of this project; is to determine the effect of the Metaverse-Based Healthy Life Program to be developed in the project to support youths in decreasing future risks of developing non-communicable diseases (NCDs) and in gaining healthy lifestyle behaviors (HLBs).
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Metaverse in Mental Health: The Beginning of a Long History.
Cerasa A, Gaggioli A, Pioggia G, Riva G. · · 2024 · cited 11× · PMID 38602624 · DOI 10.1007/s11920-024-01501-8 -
MetaRehabVerse: The Great Opportunity to Put the Person's Functioning and Participation at the Center of Healthcare.
Morone G, Ciancarelli I, Calabrò RS, Cerasa A, et al · · 2025 · cited 3× · PMID 39754509 · DOI 10.1177/15459683241309587
Verify or expand the search:
- PubMed search for NCT05332886
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Health Risk Behaviors
Currently open trials in the same condition.
- NCT07032480 — Association Between Sleep Disorders, Neck Pain, and Depression · recruiting
- NCT06181929 — A Prospective Study for the Early Diagnosis of Lung Cancer in Korean Females · NA · recruiting
- NCT05665179 — Removing Barriers: Community Partnering for Innovative Solutions to the Opioid Crisis · NA · recruiting
- NCT03292094 — The African-PREDICT Study · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05332886 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ayşegül İşler Dalgıç
- Last refreshed: 18 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05332886.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing